|
N'-(3,5-dichloro-2-hydroxybenzylidene)benzohydrazide |
|
Escherichia Salmonella |
TTSS (Type III secretion system) TTSS (SPI-1 encode); TTSS (SPI-2 encode) |
Preclinical (in vitro) Preclinical (in vitro) |
Tree JJ, et al. 2009. Infect Immun; Wang D, et al. 2011. J Biol Chem Negrea A, et al. 2007. Antimicrob Agents Chemother |
|
N-[3-(2-amino-1H-imidazol-5-yl)phenyl]-4-pentylbenzamide;hydrochloride |
Depiction based on curated SMILES
HN
ClH
H
2
N
N
H
N
H
3
C
O
|
Escherichia |
Biofilm |
Preclinical (in vitro) |
Bunders CA, et al. 2010. Bioorg Med Chem Lett |
|
N-[4-(2-amino-1H-imidazol-5-yl)phenyl]-3,5-difluorobenzamide;hydrochloride |
Depiction based on curated SMILES
N
H
ClH
F
F
O
H
2
N
N
H
N
|
Escherichia Pseudomonas |
Biofilm Biofilm |
Preclinical (in vitro) Preclinical (in vitro) |
Bunders CA, et al. 2010. Bioorg Med Chem Lett
|
|
N-[4-(2-amino-1H-imidazol-5-yl)phenyl]-4-pentylbenzamide;hydrochloride |
Depiction based on curated SMILES
N
H
ClH
H
2
N
N
H
N
CH
3
O
|
Escherichia |
Biofilm |
Preclinical (in vitro) |
Bunders CA, et al. 2010. Bioorg Med Chem Lett |
|
N-[[(E)-(3,5-dichloro-2-hydroxyphenyl)methylideneamino]carbamothioyl]-2,2-dimethylpropanamide |
Depiction based on curated SMILES
N
OH
Cl
Cl
CH
3
NH
S
N
H
O
H
3
C
H
3
C
|
Escherichia |
TTSS (Type III secretion system) |
Preclinical (in vitro) |
Gauthier A, et al. 2005. Antimicrob Agents Chemother |
|
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |
| | |